About Molecular Health
Molecular Health is a Healthcare company based in Heidelberg (Germany) founded in 2004 by Friedrich Von Bohlen. Genomic software solutions for healthcare providers are developed and offered. Molecular Health has raised $26.92 million across 1 funding round from investors including dievini. The company has 121 employees. Its chief executive, as recorded, is Friedrich Von Bohlen. Molecular Health offers products and services including MH Guide CAS, AI Pharma Solutions, and Dataome. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Drug Discovery.
Company details
Genomic software solutions for healthcare providers. Its proprietary Dataome platform is a SaaS product and is capable of converting both structured and unstructured NGS data into clinically actionable results. The Dataome Knowledgebase contains information for 97k drugs, 54M drug names, 4.6M drug interactions, 85k genomic variants, and 109k clinical trials. Currently, Molecular Health has three products based on its technology. MH Guide Labs converts genetic variant data into a comprehensive tumor profile to enable labs with NGS capabilities. MH Guide Hospitals is an enterprise solution that uses sequencing data to evaluate drug efficacy, drug-drug interactions, and drug-patient compatibility for tailored cancer therapies. MH Effect is a specialized product that predicts drug-drug interactions and drug-induced adverse effects by using patient genomic data.
- Headquarters Heidelberg, Germany
- Employees 121
- Founders Friedrich Von Bohlen
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website molecularhealth.com/us-en/home
- Social LinkedIn X Facebook
- Annual Revenue$790.96 K (USD)184as on Dec 31, 2018
- Net Profit$50.3 M (USD)362as on Dec 31, 2019
- EBITDA-$50.3 M (USD)-162as on Dec 31, 2019
- Total Equity Funding$26.92M (USD)
in 1 rounds
- Latest Funding Round$26.92M (USD), Private Equity Round
Nov 2015
- Investors
- Employee Count121
Products & Services of Molecular Health
Molecular Health offers a comprehensive portfolio of products and services, including MH Guide CAS, AI Pharma Solutions, and Dataome.
Software for annotating genetic tumor data and clinical trials.
Platform providing insights for pharmaceutical data analysis.
Tool for advanced analyses in drug development processes.
Funding Insights of Molecular Health
Molecular Health has successfully raised a total of $26.92M through 1 strategic funding round. The most recent funding activity was a Private Equity Round of $26.92 million completed in November 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $26.92M
- Total Rounds 1
- Last Round Private Equity Round — $26.92M
- First Round $26.92M
(Nov 2015)
- Investors Count 1
All 1 funding rounds of Molecular Health with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2015 | $26.92M | Private Equity Round | – | Dievini | – |
1 investors in total: 1 institutional.
Investors in Molecular Health
Molecular Health has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include dievini.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investments are made in life and health sciences companies. | dievini.de | Germany |
Investor details for Molecular Health
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Molecular Health
14 people are tracked at Molecular Health (7 in leadership, 7 in team); the tracked headcount is 121.
| Name | Role | Group |
|---|---|---|
Friedrich Von Bohlen | Founder & CEO | Leadership |
Thorsten Vogt | Head Of Human Resources | Leadership |
Christian Groth | VP Of Development | Leadership |
Friedrich Von Bohlen Und Halbach | Chief Executive Officer | Leadership |
Martina Füller | Vice President Corporate Quality Management | Leadership |
Stephan Brock | Chief Technology Officer | Leadership |
Melanie Baumhögger | Head Of Finance | Leadership |
Tan Vu | Full Stack Engineer | Team |
Stephan Hettich | Svp, Business Development MH | Team |
Niels Bojunga | SVP Of Quality Management | Team |
Magesh Kumar Kalidasan Senthi Kumaar | Senior Test Manager | Team |
Luis Bersier | Senior Application Developer | Team |
Jubin Shah | Senior Application Specialist – Clinical Decision Support Software | Team |
Sagheer Ahmad | Full Stack Engineer | Team |
Complete people profiles for Molecular Health
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Molecular Health
2 dated milestones of Molecular Health across 11 years, from founding to its latest funding, stage changes and deals.
- Founded Molecular Health is founded.
- Funding First funding round of $26.9M.
Web traffic of Molecular Health
Websites that share an audience with Molecular Health (molecularhealth.com).
Websites whose visitors overlap most with Molecular Health. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| bio-pro.de | 100% | 6K | #4,456,553 | View details | |
precisiontherapeutics.com | precisiontherapeutics.com | 87% | – | ||
| obroncology.com | 81% | View details | |||
roche.de | roche.de | 61% | #617,366 | – | |
| cegat.com | 59% | 30.6K | #1,030,162 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 10 similar websites and full traffic analytics for Molecular Health
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 10 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Molecular Health
Complete news archive for Molecular Health
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Molecular Health
Molecular Health was founded in 2004 and raised its 1st funding round 11 years after it was founded.
Molecular Health is headquartered in Heidelberg, Germany. It is registered at Heidelberg, Baden-wurttemberg, Germany.
Friedrich Von Bohlen is the CEO of Molecular Health, as recorded in our data. They have also founded this company.
Molecular Health is a funded company, having raised a total of $26.92M across 1 funding round to date. The company's 1st funding round was a Private Equity Round of $26.92M, raised on Nov 2015.
Molecular Health has 121 employees.
Annual revenue of Molecular Health is $790.96K as on Dec 31, 2018.
Genomic software solutions for healthcare providers. Its proprietary Dataome platform is a SaaS product and is capable of converting both structured and unstructured NGS data into clinically actionable results. The Dataome Knowledgebase contains information for 97k drugs, 54M drug names, 4.6M drug interactions, 85k genomic variants, and 109k clinical trials. Currently, Molecular Health has three products based on its technology. MH Guide Labs converts genetic variant data into a comprehensive tumor profile to enable labs with NGS capabilities. MH Guide Hospitals is an enterprise solution that uses sequencing data to evaluate drug efficacy, drug-drug interactions, and drug-patient compatibility for tailored cancer therapies. MH Effect is a specialized product that predicts drug-drug interactions and drug-induced adverse effects by using patient genomic data.
Molecular Health offers MH Guide CAS, AI Pharma Solutions, and Dataome.
Molecular Health has 1 investor. Key investors include dievini.